Clinical Trials
24
Active:0
Completed:8
Trial Phases
3 Phases
Phase 1:2
Phase 3:12
Not Applicable:5
Drug Approvals
39
FDA:30
NMPA:9
Drug Approvals
Trientine Hydrochloride Capsules
- Product Name
- 盐酸曲恩汀胶囊
- Approval Number
- 国药准字HJ20240064
- Approval Date
- Jun 28, 2024
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字HJ20220098
- Approval Date
- Dec 30, 2022
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字HJ20220099
- Approval Date
- Dec 30, 2022
NMPA
Deferasirox Dispersible Tablets
- Product Name
- 地拉罗司分散片
- Approval Number
- 国药准字HJ20210082
- Approval Date
- Dec 14, 2021
NMPA
Deferasirox Dispersible Tablets
- Product Name
- 地拉罗司分散片
- Approval Number
- 国药准字HJ20210081
- Approval Date
- Dec 14, 2021
NMPA
Deferasirox Dispersible Tablets
- Product Name
- 地拉罗司分散片
- Approval Number
- 国药准字HJ20210080
- Approval Date
- Dec 14, 2021
NMPA
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 3
12 (63.2%)Not Applicable
5 (26.3%)Phase 1
2 (10.5%)No trials found
News
No news found